What it's for (Indications)
- Benzydamine hydrochloride is a topically acting non-steroidal anti-inflammatory drug (NSAID) primarily indicated for the symptomatic relief of pain and inflammation associated with various conditions of the mouth and throat.
- Its applications include the alleviation of discomfort from inflammatory oral conditions such as pharyngitis, tonsillitis, aphthous ulcers (canker sores), stomatitis, gingivitis, and periodontitis.
- It is also widely utilized for managing pain and inflammation that may arise following dental surgical procedures, such as tooth extractions, gum surgery, or other periodontal interventions.
- Furthermore, benzydamine is often prescribed to mitigate the symptoms of oral mucositis, a common and often debilitating side effect associated with radiation therapy and chemotherapy for cancer treatment, providing much-needed local analgesic and anti-inflammatory relief to improve patient comfort and quality of life.
- The therapy is generally aimed at short-term symptomatic management.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For the Niflam Mouthwash 250 ml Bottle formulation (typically 0.15% benzydamine hydrochloride), the standard adult dosage involves rinsing the mouth or gargling with 15 mL of undiluted solution. This procedure should be performed 2 to 3 times daily, or as advised by a healthcare professional, maintaining the rinse in the mouth for approximately 30 seconds to 1 minute before expelling it. It is crucial to not swallow the mouthwash. For children aged 6 to 12 years, a reduced dosage of 5 to 15 mL, depending on the severity of symptoms and the child's ability to gargle without swallowing, may be recommended, strictly under adult supervision to prevent accidental ingestion. Use should generally be limited to short-term relief, typically not exceeding seven days, unless otherwise directed by a physician. If symptoms persist or worsen after this period, medical evaluation is necessary. |
Safety & Warnings
Common Side Effects
- While benzydamine hydrochloride is generally well-tolerated when used topically, some side effects may occur.
- The most common adverse reactions are local in nature and include a temporary sensation of oral numbness, a stinging or burning sensation in the mouth or throat, and occasionally a feeling of dryness or thirst.
- Alterations in taste perception are rare but have been reported.
- Due to minimal systemic absorption, generalized adverse effects are infrequent but can include nausea, vomiting, headache, dizziness, or skin rash in highly sensitive individuals.
- Allergic reactions, though exceptionally rare with topical use, can manifest as itching, urticaria (hives), photosensitivity, or, in severe cases, anaphylaxis or angioedema.
- Should any of these more severe reactions occur, or if local irritation persists or worsens despite discontinuing use, immediate medical attention is warranted.
- Patients should be advised to discontinue use and consult a healthcare professional if any unexpected or persistent adverse effects are experienced.
Serious Warnings
- Black Box Warning: Benzydamine hydrochloride, when used topically as an oral rinse or spray, does not carry an FDA-mandated Black Box Warning. However, serious warnings are warranted to ensure safe and appropriate use. This medication is intended for oral topical use only and must not be swallowed. Accidental ingestion of significant quantities, particularly by children, may lead to systemic effects such as nausea, vomiting, abdominal pain, dizziness, or headache, consistent with overdose of an NSAID-like compound. Patients with a known history of hypersensitivity to benzydamine or any excipients in the formulation, including local anesthetics or NSAIDs, should avoid its use. Furthermore, if local irritation, burning, or a severe allergic reaction (e.g., rash, itching, swelling of the face/throat, severe dizziness, trouble breathing) occurs, discontinue use immediately and seek urgent medical attention. Prolonged use beyond the recommended duration without medical consultation is strongly discouraged, as it may mask underlying conditions requiring specific treatment. This product often contains alcohol; caution is advised for individuals with alcohol sensitivity or those for whom alcohol consumption is contraindicated.
- Benzydamine hydrochloride oral rinse is intended strictly for topical oral use; it must not be swallowed.
- Accidental ingestion of significant quantities, particularly in children, could lead to systemic adverse effects such as gastrointestinal upset (nausea, vomiting), dizziness, or headache, necessitating immediate medical consultation.
- Patients with a known history of bronchial asthma should exercise caution, as, like other NSAIDs, benzydamine could theoretically induce bronchospasm in susceptible individuals, although systemic absorption is low.
- Prolonged use of benzydamine oral rinse for more than seven days without medical supervision is not recommended, as it may mask symptoms of underlying oral or pharyngeal pathologies requiring specific diagnostic and therapeutic interventions.
- If symptoms do not improve or worsen within this timeframe, or if new symptoms develop, patients should seek professional medical advice.
- Some formulations of benzydamine mouthwash contain ethanol (alcohol); this should be considered for patients with alcohol intolerance, those taking disulfiram, or individuals for whom alcohol consumption is contraindicated.
- Pregnant and breastfeeding women should consult their healthcare provider before use, as comprehensive safety data in these populations are limited, and systemic exposure, even if minimal, should be carefully weighed against potential risks.
How it Works (Mechanism of Action)
Benzydamine hydrochloride is a locally acting non-steroidal anti-inflammatory drug (NSAID) that exhibits potent anti-inflammatory, analgesic, and local anesthetic properties. Its primary mechanism of action involves the stabilization of biological membranes and interference with cellular oxidative processes, which ultimately contributes to the inhibition of prostaglandin synthesis. Unlike conventional NSAIDs that primarily target cyclooxygenase (COX) enzymes, benzydamine's anti-inflammatory effects are believed to be mediated through a broader spectrum of actions, including inhibition of phospholipase A2 and modulation of cytokine production, leading to a reduction in the inflammatory cascade. The analgesic effect is twofold: it directly reduces pain by diminishing the production of pain-mediating inflammatory chemicals and also exerts a local anesthetic effect by blocking neuronal impulse conduction at the site of application. This localized action minimizes systemic absorption, thereby reducing the risk of systemic side effects typically associated with oral NSAID administration, making it particularly suitable for managing localized oral and pharyngeal inflammation and pain.
Commercial Brands (Alternatives)
No other brands found for this formula.